vimarsana.com

Page 7 - மைய மருந்துகள் தரநிலை கட்டுப்பாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

16 States keen on developing medical devices parks - The Hindu BusinessLine

16 States keen on developing medical devices parks February 23, 2021 Telangana promotes medical device manufacturing in a big way The Union government is scrutinising applications received from 16 States that showed interest in promoting medical devices parks, according to S Eswara Reddy, Joint Drugs Controller at the Central Drugs Standard Control Organisation. Addressing a session on ‘Medical Technologies – the next big opportunity for India’ at the BioAsia-2021 on Tuesday, he said the government had introduced an incentive-based scheme to encourage indigenous production of medical devices. The Government has already cleared a few categories of medical devices under the PLI (Production Linked Incentive) scheme. The salient feature of the scheme is that the government will provide 5 per cent incentive on incremental sales of devices manufactured in the country,” he said.

Global Coronavirus Infections Reach 104M with 2 2M Deaths

Global Coronavirus Infections Reach 104M with 2 2M Deaths
newzealandstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newzealandstar.com Daily Mail and Mail on Sunday newspapers.

Pfizer withdraws COVID vaccine emergency use bid in India

Pfizer withdraws COVID-19 vaccine emergency use bid in India Celine Castronuovo © Getty Images Pfizer withdraws COVID-19 vaccine emergency use bid in India Pfizer has removed its bid for emergency approval of its coronavirus vaccine in India, citing additional information needed by the country s drug regulator, the pharmaceutical company confirmed to The Hill. The decision, first reported by Reuters on Friday, came after a Wednesday meeting with India s Central Drugs Standard Control Organization. Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time, Pfizer said in a statement shared with The Hill.

COVID-19: How India will vaccinate 300 million people in 8 months

How do you vaccinate a country of 1.3 billion? A gargantuan task indeed. That’s the challenge facing India as it launched a vaccination programme on January 16 to fight the coronavirus pandemic. Size and numbers have never intimidated India. After all, the country has been successfully running the world’s largest democratic exercise for more than seven decades. So the COVID-19 vaccination programme shouldn’t be too difficult despite the enormous hurdles. Much like the rest of the world, India has been reeling from the onslaught of the coronavirus. COVID-19 infections have surged so much that India is second only to the United States with more than 10.5 million cases and over 150,000 deaths. The economy also has taken a hit. The country applied lockdowns early last year, yet the infections keep soaring. So vaccination offers the best solution to prevent the spread of the virus.

COVID-19 Vaccination: Here s Which Vaccine States Have Received And What They Have Planned

COVID-19 vaccination: Here’s which vaccine states have received and what they have planned The Health Ministry has clarified that both the approved vaccines - Covishield and COVAXIN - will be treated at par. January 16, 2021 / 07:13 AM IST India is set to start its COVID-19 vaccination drive from January 16 with two vaccines - Covishield and COVAXIN. The Drugs Controller General of India (DCGI) had on January 3 granted emergency use authorisation to the two COVID-19 vaccines developed by Oxford University and AstraZeneca, manufactured by the Serum Institute of India (SII), and Bharat Biotech, respectively. According to the government, 1.1 crore vials of Covishield and 55 lakh vials of Bharat Biotech have been ordered.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.